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Abstract
Aims: The aim of the study was to assess the concordance of care for age related macular degeneration with the evidence-
based framework for care for chronic medical conditions known as the chronic care model. Furthermore we aimed to
identify factors associated with the concordance of care with the chronic care model.
Methods: Multi-centered cross-sectional study. 169 patients beginning medical treatment for age related macular
degeneration were recruited and analyzed. Patients completed the Patient Assessment of Chronic Illness Care (PACIC)
questionnaire, reflecting accordance to the chronic care model from a patient’s perspective, the National Eye Institute Visual
Functioning Questionnaire-25 (NEI-VFQ-25) and Patient Health Questionnaire (PHQ-9). Visual acuity and chronic medical
conditions were assessed. Nonparametric tests and correlation analyses were performed, also multivariable regression
analysis.
Results: The median PACIC summary score was 2.4 (interquartile range 1.75 to 3.25), the lowest PACIC subscale score was
‘‘follow-up/coordination’’ with a median of 1.8 (interquartile range 1.00 to 2.60). In multivariable regression analysis the
presence of diabetes type 2 was strongly associated with low PACIC scores (coefficient =20.85, p = 0.007).
Conclusion: Generally, care for patients with age related macular degeneration by ophthalmologists is in moderate
concordance with the chronic care model. Concerning follow-up and coordination of health service, large improvements are
possible. Future research should answer the question how healthcare delivery can be improved effecting relevant benefits
to patients with AMD.
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Introduction
Health care in general is being challenged by the unprecedented
increase in chronic conditions. [1,2] The need to react to this
epidemiological transition has led to initiatives, targeting to
improve care for chronic conditions. [3] The chronic care model
(CCM) developed by Wagner and colleagues is an evidence-based
multifaceted recommendation package, targeting to improve care
in different categories that are regarded as determinants for
adequate care of chronic conditions. [4–6] These categories are
organization of healthcare, clinical information systems, delivery-
system design, decision support, self-management support and
community resources. The CCM is supported by the WHO and
has gained widespread acceptance because interventions enhanc-
ing the concordance with the CCM effectively improved relevant
outcomes in chronic diseases such as diabetes, osteoarthritis or
depression. [7–9] A validated tool to measure the concordance of
care with the CCM from the patient’s perspective has been
developed [10].
Age related macular degeneration (AMD) is a chronic condition
with severe potential impact on diseased patients. In AMD, visual
loss is for the greatest part triggered by the growth of abnormal
blood vessels in proximity of the retina. These abnormal blood
vessels cause leakage of blood constituents with consecutive
anatomic disruption, cell death and ultimately loss of central
vision. The growth of new blood vessels including the conse-
quences on visual function, however, can be effectively antago-
nized by therapies targeting the vascular endothelial growth factor
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A (VEGF-A). [11] These therapies are applied by periodic
intravitreal injections. Current treatment strategies aim to
administer injections in phases of disease activity notable by
sudden deteriorations of visual function. [12,13] This individual-
ized and patient-centered approach potentially reduces unneces-
sary injections, however, it requires health services to provide a
thorough follow-up management. Furthermore patients need to be
adequately informed and empowered as they take great respon-
sibility by self-monitoring their disease. This is especially important
in stages of presumed disease inactivity, when re-occurrence of
neovascularizations should prompt immediate re-uptake of an
anti-VEGF-A therapy capable of slowing down or even avert
permanent visual loss. Such features of healthcare delivery are
represented in the CCM, which is therefore relevant in AMD on
both the caregivers’ and the patients’ levels. Whether care for
AMD is in concordance with the CCM, however, is currently
unknown.
The aim of this study was to assess if and to what extent care for
patients with AMD is in concordance with the CCM in Swiss
ophthalmology clinics (1). Furthermore we aimed to identify
factors that determine the concordance of care with the CCM (2).
Materials and Methods
Study design
This is a cross-sectional study, based on the baseline data
gathered for the randomized trial ‘‘The chronic care for age-
related macular degeneration study’’ (CHARMED). The study has
been registered at Current Controlled Trials (ISRCTN32507927),
the study protocol is publically available. [14] In brief about 20
ophthalmologists from 20 leading ophthalmology clinics in
Switzerland providing therapy for patients with AMD were
invited to participate in the study by a formal letter. Participating
ophthalmologists where trained to gather outcome measures in a
standardized format. Also in every participating clinic chronic care
coaches where trained to deliver chronic care and conduct
structured interviews for outcome measurements. According to the
trial’s power calculation 352 patients where intended to be
recruited, however, recruiting was stopped after 20 months when
the number of newly recruited patients per month reached zero.
Ethics statement
Ethics committee approval was obtained (ethics committee of
the Canton Zurich, KEK-ZH-NR: 2010-04391/1). The study was
performed adhering to the tenets of the Declaration of Helsinki
and according to Good Clinical Practice Guidelines.
Patients
Patients were recruited consecutively from April 1 2011 until
January 28 2013 by the participating ophthalmologists during
clinical visits.
To be eligible for inclusion, patients were required to meet the
following inclusion criteria: Diagnosis of wet AMD, age above 50
years, eligible for antiangiogenic drug therapy and visual acuity of
at least 20 letters in the assessment with the Early Treatment
Diabetic Retinopathy Study (ETDRS) chart. Written informed
consent in the study participation was obtained before any study
related procedures were taken. Exclusion criteria were former
invasive medical treatment for AMD, severe general illness (i.e.
advanced malignant tumors or dementia), severe psychological
illness and insufficient German or French language skills.
Measures and data collection
Data collection was performed directly after written informed
consent was obtained. A questionnaire was filled in by the
ophthalmologists containing the following measures retrieved at
the recruitment visit: Visual acuity (using ETDRS charts,
standardized measurements were assured by conducting a visit
with a teaching session at each ophthalmology clinic); central
retinal thickness by optical coherence tomography; specific
comorbidities such as hypertension, diabetes type 2, diabetic
retinopathy, coronary artery disease, congestive heart failure,
stroke or transient ischemic attack, asthma or chronic obstructive
lung disease and neoplasms; family anamnesis of wet AMD;
smoking status; current medication; estimation of the patients
compliance on a four-point scale (range from 1= very good to
4= very bad).
A second questionnaire was given to the patients at the
recruiting visit to fill in and return directly to the University of
Zurich using a readily stamped and accordingly addressed
envelope. The questionnaire was self-administered and contained
the Patient Assessment of Chronic Illness Care (PACIC) as a
measure for concordance of care with the CCM, [10] the PHQ-9
questionnaire as a measure for depression [15] and questions
about socio-demographic data and health service utilization.
The PACIC is a validated self-administered instrument that
measures the concordance of care with the CCM from the
patient’s perspective. According to the key-elements of the CCM
the PACIC is organized containing five essential categories of
chronic care asked in 20 individual items. In specific these
categories are patient activation, delivery system design/decision
support, goal setting/tailoring, problem solving/contextual coun-
selling and follow-up/coordination. Each of the individual items
are scored on a five point Likert-scale ranging from ‘‘almost
never’’ ( = 1, corresponding to poorest concordance with the
CCM) to ‘‘almost always’’ ( = 5, corresponding to highest
concordance with the CCM). The PACIC summary score is the
mean score of the 20 individual items and gives an overall rating of
the concordance with the CCM. Five subscales are defined that
allow estimations of the CCM concordance with the respective
essential categories of chronic care. Such as the CCM, the PACIC
itself has shown to be associated with favorable outcomes in
chronic conditions. [16] The PACIC summary score was our
predefined primary outcome.
The Patient Health Questionnaire (PHQ-9) is a self-adminis-
tered tool that allows rapid screening for depression and rating
severity that recently has showed consistency in patients with
visual impairment. [17,18] The PHQ-9 was introduced in the
measurements as a confounder control, because depression is
known to be highly prevalent among patients with AMD and
might influence outcomes of the CHARMED randomized trial
(not discussed in this article) [19].
In a face-to-face or telephone interview with the patients the
trained chronic care coaches operated the National Eye Institute
Visual Functioning Questionnaire-25 (NEI-VFQ-25) in the
interviewer administered format. [20] The NEI-VFQ-25 is a
validated measure of the visual disability specific quality of life and
functioning, it consists of 25 vision-targeted questions that generate
11 subscales of vision related health and functioning [21,22].
Patients and ophthalmologists’ answers remained concealed
from each other; the University of Zurich had no access to the
patients’ personal informations ensuring anonymity.
Statistical analysis
Continuous variables are presented as means and standard
deviations or medians and interquartile ranges if not otherwise
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declared; categorical data is presented as frequencies and
percentages. Bivariate association between the PACIC summary
score and continuous variables were conducted using Spearman
correlations, between PACIC summary score and categorical
variables using Mann-Whitney-U Test and Kruskal-Wallis Test
(more than two groups). Potential determinants of the PACIC
summary score were investigated by multivariable regression
model. We included all variables in the model that showed both a
significant bivariate relationship with the PACIC summary score
on a 5% level and could be interpreted in terms of content as
potential determinants. We further controlled for the cluster-effect
of clinics, thus taking into account that patient observations are not
independent, i.e. observations in one cluster tend to be more
similar to each other than to individuals in the rest of the sample.
A two-sided alpha of 0.05 was set as level of significance for all
comparisons. Missing data were left as missing, for the construc-
tion of the PACIC summary score one missing item (out of 20) was
allowed. Analyses were calculated using the software SPSS version
21.0 and STATA version 12.
Results
Ophthalmologist characteristics
Twelve different ophthalmologists from twelve different clinics
could be recruited for the study. Amongst the clinics, three
different categories of organization type were found: Three clinics
were single handed practices (median number of patients
recruited = 7, range 2–12), five clinics were group practices
(median number of patients recruited = 5, range 1–18), four were
clinics run within hospitals (median number of patients recruit-
ed = 25, range 11–54).
Patient characteristics and clinical measures
In total, 169 patients were enrolled in the study. 21 (12.4%)
patients were recruited in single handed practices, 32 (18.9%) in
group practices and 116 (68.6%) in clinics run within hospitals.
107 (63.3%) of the patients were female, the mean age was 76.7
(68.0) years. The average of total education years absolved was
12.0 (63.4). In all patients, treatment with ranibizumab was
started. Further characteristics are shown in Table 1.
Table 1. Demographical and social characteristics of study patients, smoking status and patient compliance from the
ophthalmologist’s perspective; table n= 169.
Variable Category n percent
Gender Male 62 36.7
Female 107 63.3
Missing information 0 0.0
Age ,60 years old 3 1.8
60–69 years old 33 19.5
70–79 years old 69 40.8
80–89 years old 58 34.3
$90 years old 6 3.6
Missing information 0 0.0
Living situation Living with partner or family 103 60.9
Living alone 53 31.4
Missing information 13 7.7
Working situation Still working 12 7.1
Retired 144 85.2
Missing information 13 7.7
Education years completed #6 years 2 1.2
7 to 9 years 41 24.3
10 to 12 years 56 33.1
$13 years 56 33.1
Missing information 14 8.3
Smoking status Current smoker 26 15.4
Former smoker 49 29.0
Never smoker 94 55.6
Missing information 0 0.0
Compliance Very good 96 56.8
Rather good 69 40.8
Rather bad 3 1.8
Very bad 1 0.6
Missing information 0 0
doi:10.1371/journal.pone.0108536.t001
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The mean number (6 standard deviation) of correctly identified
ETDRS letters was 74.1 (614.9) with the better eye and 52.6
(618.9) with the worse eye. The mean (6 standard deviation)
NEI-VFQ-25 composite score was 83.8 (612.4). The mean
general health rating (not component of the composite score) was
54.6 (619.5). Detailed vision-specific information is given in
Table 2.
In 111 (65.7%) of the patients at least one co-occurring chronic
medical condition was present. 99 (58.6%) of the patients had
cardiovascular comorbidities. The median number of ophthal-
mologist consultations within one year was 2 (interquartile range 1
to 3), the median number of GP consultations was 3 (interquartile
range 1 to 6). 37 (21.9%) patients had at least one hospitalization
during the last year, 27 (16.0%) had emergency hospitalizations.
Data about comorbidities and healthcare utilization is displayed in
Table 3.
PACIC scores
The median PACIC summary score was 2.4 (interquartile range
1.75 to 3.25). There were substantial differences between the
different PACIC subscale scores. The subscale score ‘‘follow-up/
coordination’’ resulted lowest with a median subscale score of 1.8
(interquartile range 1.00 to 2.60), corresponding with an average
rating of the items in the PACIC questionnaire somewhat lower
than ‘‘generally not’’. The highest subscale score was ‘‘delivery
system design/decision support’’ with a median subscale score of
3.7 (interquartile range 2.33 to 4.67), corresponding with an
average rating of the items in the PACIC questionnaire between
‘‘sometimes’’ and ‘‘most of the time’’. Details about the
distribution of the PACIC summary score and subscale results
are displayed in Table 4 and Figure 1.
Bivariate associations with PACIC summary score
The PACIC summary score was not significantly associated
with the practice organization type (single handed, group practices
and ambulatory clinics in hospitals: independent sample Kruskal-
Wallis Test p = 0.187). No significant associations with the PACIC
summary score were found for patients’ socio-demographic
characteristics, smoking status or physician-reported compliance.
Also no significant association with the PACIC summary score was
found for the number of comorbidities and for the PHQ-9. The
presence of diabetes type 2 was significantly associated with lower
PACIC scores (median [interquartile range] PACIC summary
score of group with diabetes type 2= 1.5 [1.11 to 2.13]), group
without diabetes type 2= 2.7 [1.83 to 3.28]; Mann Whitney U
Test p = 0.002). Also the presence of coronary artery disease was
significantly associated with lower PACIC scores (median [inter-
quartile range] PACIC summary score of group with coronary
artery disease = 2.0 [1.37 to 2.89]), group without coronary artery
disease = 2.7 [1.80 to 3.30]; Mann Whitney U Test p = 0.037). No
Table 2. Vision-specific variables of study patients: visual acuity was assessed with the Early Treatment Diabetic Retinopathy Study
(ETDRS) Chart; disability was assessed with the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25), range 0 to
100 (0 represents worst, 100 represents best possible visual functioning); table n = 169.
Variable Category Mean Standard deviation n Percent
ETDRS Visual acuity better eye Total ETDRS letters correct 74.1 14.9
,31 ETRDS letters correct 4 2.4
31–50 ETRDS letters correct 9 5.3
51–70 ETRDS letters correct 30 17.8
.70 ETRDS letters correct 118 69.8
Missing information 8 4.7
ETDRS Visual acuity worse eye Total ETDRS letters correct 52.6 18.9
,31 ETRDS letters correct 18 10.7
31–50 ETRDS letters correct 48 28.4
51–70 ETRDS letters correct 68 40.2
.70 ETRDS letters correct 27 16.0
Missing information 8 4.7
NEI-VFQ-25 subscales* General health 54.6 19.5
General vision 67.0 13.6
Ocular pain 90.0 15.8
Near activities 76.4 20.6
Distant activities 79.9 19.9
Social functioning 94.0 14.2
Mental health 78.7 18.7
Role difficulties 82.1 24.6
Dependency 93.8 17.0
Driving 68.8 33.9
Color vision 96.2 13.8
Peripheral vision 88.7 18.9
*) Missing information for all items ranged from 6 to 8, except for ‘‘Driving’’ which was unanswered in 83 cases.
doi:10.1371/journal.pone.0108536.t002
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vision-specific variable showed association with the PACIC
summary score.
Multivariate associations with PACIC summary score
For the multivariable regression model we considered the
comorbidity diabetes type 2 and coronary artery disease (both
significant in bivariate analysis), gender and age (potential
confounders) and visual acuity of the better eye (as an indicator
for the severity of visual loss). The model was controlled for the
cluster-effect originating from the different study clinics.
After application of the model, the only significant determinant
of the PACIC summary score was diabetes type 2 (coefficient =
20.85, p = 0.007). Coronary artery disease closely missed signif-
icance (coefficient =20.44, p = 0.059), the other variables showed
no association (Table 5).
Discussion
The CCM is an evidence-based template for the care for
patients with chronic illnesses. We aimed to measure the
concordance of care with the CCM in patients treated for
AMD. We found that patients perceived moderate overall
concordance with the CCM, especially low concordance was
found in the ‘‘follow-up/coordination’’ subscale score.
A broad spectrum of different types of ophthalmology clinics
participated in the study. Interestingly the PACIC summary score
Table 3. Comorbidity and Health Service Utilization; table n = 169.
Variable Category n percent
Number of comorbidities 0 comorbidities 58 34.3
1 comorbidity 60 35.5
2 comorbidities 34 20.1
3 comorbidities 10 5.9
$4 comorbidities 6 3.6
Missing information 1 0.6
Specific comorbidities Hypertension 92 54.4
Diabetes type 2 14 8.3
Diabetic retinopathy 0 0.0
Coronary artery disease 29 17.2
Congestive heart failure 8 4.7
Stroke/TIA1) 14 8.3
Asthma/COPD2) 16 9.5
Neoplasm 11 6.5
Depression according to PHQ-93) No depression 116 68.6
Mild depression 32 18.9
Moderate major depression 3 1.8
Severe major depression 2 1.2
Missing information 16 9.5
Number of ophthalmologist consultations last year 1–2 consultations 87 51.5
3–4 consultations 38 22.5
5–6 consultations 14 8.3
$7 consultations 8 4.7
Missing information 22 13.0
Number of GP4) consultations last year 0–2 consultations 65 38.5
3–4 consultations 36 21.3
5–6 consultations 23 13.6
$7 consultations 31 18.3
Missing information 14 8.3
Number of days in hospital last year 0 days 117 69.2
1–3 days 8 4.7
4–10 days 18 10.7
$11 days 11 6.5
Missing information 15 8.9
1)TIA = Transient ischemic attack;
2)COPD=Chronic obstructive pulmonary disease;
3)PHQ-9 = Patient Health Questionnaire-9;
4)GP =General practitioner.
doi:10.1371/journal.pone.0108536.t003
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showed no significant association with the organization type of the
clinics. Although relevant structural differences between hospital-
run ophthalmology clinics and single handed ophthalmology
practices must be assumed, those differences did not affect the
concordance with the CCM from the patients perspective.
According to the inclusion and exclusion criteria, patients that
just newly qualified for antiangiogenic therapy were recruited in
this study. The sample is thus representative for AMD patients at
the beginning of their chronic care situation. The relatively intact
ETDRS visual acuity and the high NEI-VFQ-25 scores showed
that these patients are mostly in early stages of the disease and
have therefore the highest potential to benefit from preventive
interventions enabled by successful healthcare delivery.
PACIC scores we identified, however, were modest. The
subscale score ‘‘follow-up/coordination’’ was particularly low also
in comparison to PACIC scores from research done in other
chronic conditions such as diabetes, osteoarthritis or inflammatory
bowel disease. [23–25] In AMD, however, a low concordance of
follow-up organization with the CCM is especially undesirable
because successful follow-up is regarded to be critical for
outcomes. [26] It remains, however, debatable whether the
PACIC subscales truly represent the different domains of the
CCM, because of the high internal consistency of the total PACIC
score itself [10,27].
Furthermore, we found specific comorbidities to be associated
with low PACIC scores in ophthalmological care. In the case of
Table 4. Patient Assessment of Chronic Illness Care (PACIC) scores; range 1 to 5, 1 corresponds to poorest concordance with the
Chronic Care Model (CCM), 5 corresponds to highest concordance with the CCM; for the construction of the PACIC summary score
one missing item was allowed.
PACIC Scores Valid n Median Interquartile range
Summary score1) 131 2.4 1.75 to 3.25
Subscale ‘‘Patient activation’’ 141 3.0 1.67 to 4.67
Subscale ‘‘Delivery system
design/decision support’’
133 3.7 2.33 to 4.67
Subscale ‘‘Goal setting/tailoring’’ 138 2.2 1.30 to 3.40
Subscale ‘‘Problem solving/contextual
counselling’’
138 2.0 1.19 to 3.81
Subscale ‘‘Follow-up/coordination’’ 139 1.8 1.00 to 2.60
1)For calculation of PACIC summary score one missing item (out of twenty) in the questionnaire was allowed.
doi:10.1371/journal.pone.0108536.t004
Figure 1. Distribution of PACIC summary score and subscale scores. PACIC scores are represented in boxplots. The PACIC summary score is
displayed on the left, other boxplots are the respective PACIC subscale scores. The lower and the upper margin of the box indicate the 25th and 75th
percentile respectively. The bar inside the box indicates the median. Whiskers extend to the most extreme data point within 1.5 times the
interquartile range.
doi:10.1371/journal.pone.0108536.g001
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diabetes type 2 this is troublesome because patients with both
AMD and diabetes are in the highest need for successful chronic
care as their visual acuity is endangered by two treatable chronic
conditions simultaneously. With our data we cannot explain this
finding of co-occurring conditions being associated with decreased
PACIC scores. A possible explanation for this finding could be that
ophthalmologists feel less responsible for care for multimorbid
patients since they assume that the GP coordinates the care for
them.
Limitations
Undoubtedly, the implementation of the different important
elements of chronic care is a dynamic process requiring several
contacts of healthcare professionals with the individual patient.
Patients in our sample, however, were newly entering a chronic
care situation for AMD. The PACIC results we obtained might
therefore be representative for patients in an early stage of chronic
care implementation, thus showing the gaps that still need to be
filled. This might especially apply to our results in the ‘‘follow-up/
coordination’’ subscale. Only 131 of 169 patients provided enough
data to allow calculation of the PACIC summary score. A greater
number of cases would have provided more power to detect
significant results. Also, we cannot exclude bias from selective
answering; we assume, however, that patients dissatisfied with
their healthcare would be less motivated to answer the question-
naire, thus causing bias towards false high PACIC scores. PACIC
scores in our study would thus tend to be overestimated, the
potential for enhancements even greater. Finally, the PACIC score
reflects the patient perspective of chronic illness care only, leaving
the healthcare provider’s perspective unclear.
Conclusion
Generally, care for patients with age related macular degener-
ation by ophthalmologists is in moderate concordance with the
chronic care model. Concerning follow-up and coordination of
health service, large improvements are possible, for example with
follow-up calls by health service professionals (in order to prevent
loss of follow-up during inactive stage of the disease) or with
coordination of health service between primary care and
specialized ophthalmologic care (in order to allocate responsibil-
ities and avoid under- or overtreatment especially if additional
chronic diseases as diabetes exist). Future research should answer
the question how healthcare delivery can be improved effecting
relevant benefits to patients with AMD.
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